Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1489050, 16 pages
http://dx.doi.org/10.1155/2016/1489050
Review Article

The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases

1Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China
2Department of Neurobiology, College of Basic Medical Sciences, Third Military Medical University, Chongqing, China

Received 2 August 2016; Accepted 20 November 2016

Academic Editor: Eduardo Gonzalez-Toledo

Copyright © 2016 Shilun Zuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. T. Hien, N. J. White, and White, “Qinghaosu,” The Lancet, vol. 341, no. 8845, pp. 603–608, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Pelfrene, M.-H. Pinheiro, and M. Cavaleri, “Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency,” International Health, vol. 7, no. 4, pp. 239–246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, Guidelines for the Treatment of Malaria, WHO, Geneva, Switzerland, 3rd edition, 2015.
  4. K. Zhao and Z. Song, “Distribution and excretion of artesunate in rats,” Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College, vol. 4, no. 4, pp. 186–188, 1989. View at Google Scholar · View at Scopus
  5. H. J. Woerdenbag, T. A. Moskal, N. Pras et al., “Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells,” Journal of Natural Products, vol. 56, no. 6, pp. 849–856, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. G.-Q. Zheng, “Cytotoxic terpenoids and flavonoids from Artemisia annua,” Planta Medica, vol. 60, no. 1, pp. 54–57, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Lu, “Study on effect of Cordyceps sinensis and artemisinin in preventing recurrence of lupus nephritis,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 22, no. 3, pp. 169–171, 2002. View at Google Scholar · View at Scopus
  8. S. Jauréguiberry, M. Thellier, P. A. Ndour et al., “Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with Artesunate, France, 2011–2013,” Emerging Infectious Diseases, vol. 21, no. 5, pp. 804–812, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Gómez-Junyent, P. Ruiz-Panales, A. Calvo-Cano, J. Gascón, and J. Muñoz, “Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum,” Enfermedades Infecciosas y Microbiología Clínica, 2015. View at Publisher · View at Google Scholar
  10. F. B. Li and H. Z. Pan, “Peroxidative antimalaria mechanism of sodium artesunate,” Acta Academiae Medicinae Sinicae, vol. 11, no. 3, pp. 180–184, 1989. View at Google Scholar · View at Scopus
  11. Y. I. Zhao, W. K. Hanton, and K.-H. Lee, “Antimalarial agents, 2. Artesunate, an inhibitor of cytochrome oxidase activity in Plasmodium berghei,” Journal of Natural Products, vol. 49, no. 1, pp. 139–142, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Berdelle, T. Nikolova, S. Quiros, T. Efferth, and B. Kaina, “Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells,” Molecular Cancer Therapeutics, vol. 10, no. 12, pp. 2224–2233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Efferth and F. Oesch, “Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines,” Biochemical Pharmacology, vol. 68, no. 1, pp. 3–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Wang, L.-M. Wu, Y. Zhao, X.-L. Zhang, and N.-P. Wang, “The anticancer effect of artesunate and its mechanism,” Acta Pharmaceutica Sinica, vol. 37, no. 6, pp. 477–478, 2002. View at Google Scholar · View at Scopus
  15. S. Reichert, V. Reinboldt, S. Hehlgans, T. Efferth, C. Rödel, and F. Rödel, “A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin,” Radiotherapy and Oncology, vol. 103, no. 3, pp. 394–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Ooko, M. E. M. Saeed, O. Kadioglu et al., “Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells,” Phytomedicine, vol. 22, no. 11, pp. 1045–1054, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Jiang, B. Li, X. Zheng et al., “Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin,” International Immunopharmacology, vol. 11, no. 8, pp. 1065–1073, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Alenquer, S. Tenreiro, and I. Sá-Correia, “Adaptive response to the antimalarial drug artesunate in yeast involves Pdr1p/Pdr3p-mediated transcriptional activation of the resistance determinants TPO1 and PDR5,” FEMS Yeast Research, vol. 6, no. 8, pp. 1130–1139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Li, J. Li, X. Pan et al., “Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-κB activation,” International Immunopharmacology, vol. 10, no. 3, pp. 344–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Canivet, R. Menasria, C. Rhéaume, J. Piret, and G. Boivin, “Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone,” Antiviral Research, vol. 123, pp. 105–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. L. A. El Zawawy, “Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies,” Journal of the Egyptian Society of Parasitology, vol. 38, no. 1, pp. 185–201, 2008. View at Google Scholar · View at Scopus
  22. M. E. Sarciron, C. Saccharin, A. F. Petavy, and F. Peyron, “Effects of artesunate, dihydroartemisinin, and an artesunate- dihydroartemisinin combination against Toxoplasma gondii,” American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 73–76, 2000. View at Google Scholar · View at Scopus
  23. W. J. Le, J. Q. You, and J. Y. Mei, “Chemotherapeutic effect of artesunate in experimental schistosomiasis,” Acta Pharmaceutica Sinica, vol. 18, no. 8, pp. 619–621, 1983. View at Google Scholar · View at Scopus
  24. R. Liu, H.-F. Dong, Y. Guo, Q.-P. Zhao, and M.-S. Jiang, “Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis,” Parasites and Vectors, vol. 4, no. 1, article no. 201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Spicher, C. Roethlisberger, C. Lany et al., “In vitro and in vivo treatments of Echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 9, pp. 3447–3450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Zuo, H. Ge, Q. Li et al., “Artesunate protected blood-brain barrier via sphingosine 1 phosphate receptor 1/phosphatidylinositol 3 kinase pathway after subarachnoid hemorrhage in rats,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. U. P. Okorji and O. A. Olajide, “A semi-synthetic derivative of artemisinin, artesunate inhibits prostaglandin E2 production in LPS/IFNγ-activated BV2 microglia,” Bioorganic and Medicinal Chemistry, vol. 22, no. 17, pp. 4726–4734, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. I.-S. Lee, D.-K. Ryu, J. Lim, S. Cho, B. Y. Kang, and H. J. Choi, “Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells,” Neuroscience Letters, vol. 509, no. 1, pp. 17–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. U. C. Schneider, A.-M. Davids, S. Brandenburg et al., “Microglia inflict delayed brain injury after subarachnoid hemorrhage,” Acta Neuropathologica, vol. 130, no. 2, pp. 215–231, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Zhou and Y. Feng, “Artesunate reduces proliferation, interferes DNA replication and cell cycle and enhances apoptosis in vascular smooth muscle cells,” Journal of Huazhong University of Science and Technology Medical Sciences, vol. 25, no. 2, pp. 135–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. O. Borel, A. McKee, A. Parra et al., “Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage,” Stroke, vol. 34, no. 2, pp. 427–433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Chen, H. Feng, P. Sherchan et al., “Controversies and evolving new mechanisms in subarachnoid hemorrhage,” Progress in Neurobiology, vol. 115, pp. 64–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Clemmer, Y. C. Martins, G. M. Zanini, J. A. Frangos, and L. J. M. Carvalho, “Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 4, pp. 1383–1390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Chen, M. Kappel, M. Lemnge, I. C. Bygbjerg, T. G. Theander, and A. Kharazmi, “In vitro effects of artesunate and other antimalarial agents on the function of human lymphocytes and neutrophils,” Transplantation Proceedings, vol. 26, no. 6, pp. 3172–3174, 1994. View at Google Scholar · View at Scopus
  35. V. B. Konkimalla, M. Blunder, B. Korn et al., “Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells,” Nitric Oxide: Biology and Chemistry, vol. 19, no. 2, pp. 184–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. C. Mota, P. C. S. Cardoso, L. M. Gomes et al., “In vitro evaluation of the genotoxic and cytotoxic effects of artesunate, an antimalarial drug, in human lymphocytes,” Environmental and Molecular Mutagenesis, vol. 52, no. 7, pp. 590–594, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Yang, J. R. Kowalski, X. Zhan, S. M. Thomas, and F. W. Luscinskas, “Endothelial cell cortactin phosphorylation by Src contributes to polymorphonuclear leukocyte transmigration in vitro,” Circulation Research, vol. 98, no. 3, pp. 394–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Kubo, K. Ogasawara, S. Kakino et al., “Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage,” Surgical Neurology, vol. 69, no. 6, pp. 592–596, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Bavbek, R. Polin, A.-L. Kwan, A. S. Arthur, N. F. Kassell, and K. S. Lee, “Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits,” Stroke, vol. 29, no. 9, pp. 1930–1935, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. M. C. Souza, F. H. M. Paixão, F. K. Ferraris, I. Ribeiro, and M. D. G. M. O. Henriques, “Artesunate exerts a direct effect on endothelial cell activation and NF-κB translocation in a mechanism independent of plasmodium killing,” Malaria Research and Treatment, vol. 2012, Article ID 679090, 12 pages, 2012. View at Publisher · View at Google Scholar
  41. A. Gruber, A. Reinprecht, U. M. Illievich et al., “Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage,” Critical Care Medicine, vol. 27, no. 3, pp. 505–514, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. W. J. Schuiling, P. J. W. Dennesen, and G. J. E. Rinkel, “Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage,” Neurocritical Care, vol. 3, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Radolf, N. Smoll, C. Drenckhahn, J. P. Dreier, P. Vajkoczy, and A. S. Sarrafzadeh, “Cerebral lactate correlates with early onset pneumonia after aneurysmal SAH,” Translational Stroke Research, vol. 5, no. 2, pp. 278–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. P. M. Cobelens, I. A. C. W. Tiebosch, R. M. Dijkhuizen et al., “Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage,” Critical Care, vol. 14, article R157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Gera and J. Dhanoa, “Vivax-induced ARDS: report of two cases,” Journal of Association of Physicians of India, vol. 58, pp. 48–50, 2010. View at Google Scholar · View at Scopus
  46. W. E. Ho, C. Cheng, H. Y. Peh et al., “Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma,” Free Radical Biology and Medicine, vol. 53, no. 3, pp. 498–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. D. S. W. Ng, W. Liao, W. S. D. Tan, T. K. Chan, X. Y. Loh, and W. S. F. Wong, “Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice,” Phytomedicine, vol. 21, no. 12, pp. 1638–1644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. C. J. van Asch, M. J. Luitse, G. J. Rinkel, I. van der Tweel, A. Algra, and C. J. Klijn, “Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis,” The Lancet Neurology, vol. 9, no. 2, pp. 167–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. R. F. Keep, Y. Hua, and G. Xi, “Intracerebral haemorrhage: mechanisms of injury and therapeutic targets,” The Lancet Neurology, vol. 11, no. 8, pp. 720–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Wang, J. Fields, C. Zhao et al., “Role of Nrf2 in protection against intracerebral hemorrhage injury in mice,” Free Radical Biology & Medicine, vol. 43, no. 3, pp. 408–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. He, S. Wan, Y. Hua, R. F. Keep, and G. Xi, “Autophagy after experimental intracerebral hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 5, pp. 897–905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Hu, G. Xi, H. Jin, Y. He, R. F. Keep, and Y. Hua, “Thrombin-induced autophagy: a potential role in intracerebral hemorrhage,” Brain Research, vol. 1424, pp. 60–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Yuan, H. Shen, L. Lin, T. Su, L. Zhong, and Z. Yang, “Autophagy promotes microglia activation through beclin-1-Atg5 pathway in intracerebral hemorrhage,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. R. W. Button, F. Lin, E. Ercolano et al., “Artesunate induces necrotic cell death in schwannoma cells,” Cell Death & Disease, vol. 5, no. 10, Article ID e1466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Hamacher-Brady, H. A. Stein, S. Turschner et al., “Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production,” Journal of Biological Chemistry, vol. 286, no. 8, pp. 6587–6601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. A. M. Gopalakrishnan and N. Kumar, “Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 1, pp. 317–325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Chen, L.-M. Shou, F. Lin et al., “Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells,” Anti-Cancer Drugs, vol. 25, no. 6, pp. 652–662, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. Y.-C. Wang, S. Lin, and Q.-W. Yang, “Toll-like receptors in cerebral ischemic inflammatory injury,” Journal of Neuroinflammation, vol. 8, article 134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Wang, J. Shi, S. Lv et al., “Artesunate attenuates lipopolysaccharide-stimulated proinflammatory responses by suppressing TLR4, MyD88 expression, and NF-κB activation in microglial cells,” Inflammation, vol. 38, no. 5, pp. 1925–1932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Zhang, X.-M. Chen, B.-D. Luo et al., “Effects of artesunate on CD14 and toll-like receptor 4 in peritoneal macrophages of mice with heat stroke endotoxemia,” Chinese Journal of Industrial Hygiene and Occupational Diseases, vol. 24, no. 4, pp. 226–228, 2006. View at Google Scholar · View at Scopus
  61. L. Lai, Y. Chen, X. Tian et al., “Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats,” European Journal of Pharmacology, vol. 765, pp. 234–241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Schmid-Elsaesser, E. Hungerhuber, S. Zausinger, A. Baethmann, and H.-J. Reulen, “Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia,” Brain Research, vol. 816, no. 2, pp. 471–479, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Álvarez-Sabín, O. Maisterra, E. Santamarina, and C. S. Kase, “Factors influencing haemorrhagic transformation in ischaemic stroke,” The Lancet Neurology, vol. 12, no. 7, pp. 689–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. G. F. Hamann, Y. Okada, and G. J. Del Zoppo, “Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 6, pp. 1373–1378, 1996. View at Google Scholar · View at Scopus
  65. Y. Gasche, J.-C. Copin, T. Sugawara, M. Fujimura, and P. H. Chan, “Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 12, pp. 1393–1400, 2001. View at Google Scholar · View at Scopus
  66. Y. Xu, W. Liu, B. Fang, S. Gao, and J. Yan, “Artesunate ameliorates hepatic fibrosis induced by bovine serum albumin in rats through regulating matrix metalloproteinases,” European Journal of Pharmacology, vol. 744, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Magenta, E. Sangiovanni, N. Basilico et al., “Inhibition of metalloproteinase-9 secretion and gene expression by artemisinin derivatives,” Acta Tropica, vol. 140, pp. 77–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. M. J. A. Luitse, G. J. Biessels, G. E. H. M. Rutten, and L. J. Kappelle, “Diabetes, hyperglycaemia, and acute ischaemic stroke,” The Lancet Neurology, vol. 11, no. 3, pp. 261–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Yu, J. F. Chen, X. Shuai et al., “Artesunate protects pancreatic beta cells against cytokine-induced damage via SIRT1 inhibiting NF-κB activation,” Journal of Endocrinological Investigation, vol. 39, no. 1, pp. 83–91, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Ritz, N. P. Denswil, O. C. G. Stam, J. J. Van Lieshout, and M. J. A. P. Daemen, “Cause and mechanisms of intracranial atherosclerosis,” Circulation, vol. 130, no. 16, pp. 1407–1414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. L. Wang, Z. J. Wang, H. L. Shen, M. Yin, and K. X. Tang, “Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit,” European Journal of Pharmaceutical Sciences, vol. 50, no. 3-4, pp. 366–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Wang, Z. Wang, H. Shen, M. Yin, and K. Tang, “The hypolipidemic effect of artesunate and ursolic acid in rats,” Pakistan Journal of Pharmaceutical Sciences, vol. 28, no. 3, pp. 871–874, 2015. View at Google Scholar · View at Scopus
  73. R. T. Merrell, “Brain tumors,” Disease-a-Month, vol. 58, no. 12, pp. 678–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Karpel-Massler, M.-A. Westhoff, R. E. Kast et al., “Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines,” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 2, pp. 313–318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. R. E. Kast, J. A. Boockvar, A. Brüning et al., “A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care,” Oncotarget, vol. 4, no. 4, pp. 502–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Efferth, T. Ramirez, E. Gebhart, and M.-E. Halatsch, “Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774,” Biochemical Pharmacology, vol. 67, no. 9, pp. 1689–1700, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Czarnecka, E. Trinh, C. Lu et al., “Neuropeptide y receptor Y5 as an inducible pro-survival factor in neuroblastoma: Implications for tumor chemoresistance,” Oncogene, vol. 34, no. 24, pp. 3131–3143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Michaelis, M. C. Kleinschmidt, S. Barth et al., “Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines,” Biochemical Pharmacology, vol. 79, no. 2, pp. 130–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. Z.-G. Mao, J. Zhou, H. Wang et al., “Artesunate inhibits cell proliferation and decreases growth hormone synthesis and secretion in GH3 cells,” Molecular Biology Reports, vol. 39, no. 5, pp. 6227–6234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. R. W. Button, F. Lin, E. Ercolano et al., “Artesunate induces necrotic cell death in schwannoma cells,” Cell Death and Disease, vol. 5, no. 10, Article ID e1466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Kobayashi, M. Hirayama, Y. Komohara et al., “Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors,” Journal of Biological Chemistry, vol. 289, no. 38, pp. 26314–26326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Zhou, W. Pan, X. P. Wang, and T. S. Chen, “Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells,” Journal of Cellular Physiology, vol. 227, no. 12, pp. 3778–3786, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. Z.-Y. Zhang, S.-Q. Yu, L.-Y. Miao et al., “Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial,” Journal of Chinese Integrative Medicine, vol. 6, no. 2, pp. 134–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. S. A. K. Rasheed, T. Efferth, I. A. Asangani, and H. Allgayer, “First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases,” International Journal of Cancer, vol. 127, no. 6, pp. 1475–1485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. X. Chen, K. Han, F. Chen, C. Wu, and W. Huang, “Effects of artesunate on the invasion of lung adenocarcinoma A549 cells and expression of ICAM-1 and MMP-9,” Chinese Journal of Lung Cancer, vol. 16, no. 11, pp. 567–571, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. H.-Y. Dong and Z.-F. Wang, “Antitumor effects of artesunate on human breast carcinoma MCF-7 cells and IGF-IR expression in nude mice xenografts,” Chinese Journal of Cancer Research, vol. 26, no. 2, pp. 200–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. E. Seo, B. Wiench, R. Hamm et al., “Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres,” Phytomedicine, vol. 22, no. 4, pp. 438–443, 2015. View at Publisher · View at Google Scholar
  88. Q. Li, W. Wang, Y. Liu et al., “The biological characteristics of a novel camptothecin-artesunate conjugate,” Bioorganic and Medicinal Chemistry Letters, vol. 25, no. 1, pp. 148–152, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. W. M. Liu, A. M. Gravett, and A. G. Dalgleish, “The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies,” International Journal of Cancer, vol. 128, no. 6, pp. 1471–1480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Hou, K. E. Block, and H. Huang, “Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis,” PLoS ONE, vol. 9, no. 8, Article ID e104762, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. O. Jin, H. Zhang, Z. Gu et al., “A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL/lpr murine model of systemic lupus erythematosus,” Cellular and Molecular Immunology, vol. 6, no. 6, pp. 461–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Mani, S. S. Mondal, G. Guha et al., “Acute disseminated encephalomyelitis after mixed malaria infection (plasmodium falciparum and plasmodium vivax) with MRI closely simulating multiple sclerosis,” Neurologist, vol. 17, no. 5, pp. 276–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. J.-Q. Shi, C.-C. Zhang, X.-L. Sun et al., “Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation,” CNS Neuroscience & Therapeutics, vol. 19, no. 4, pp. 262–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Bartkovjak, R. Ianetti, K. Kutna et al., “Cerebral malaria in children in South Sudan: 8 years experience in 261 cases,” Neuroendocrinology Letters, vol. 28, no. 2, pp. 45–46, 2007. View at Google Scholar · View at Scopus
  95. A. M. Dondorp, C. I. Fanello, I. C. Hendriksen et al., “Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial,” The Lancet, vol. 376, no. 9753, pp. 1647–1657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Mwita, L. Mwai, and C. Newton, “Antiepileptic properties of quinine: a systematic review,” Annals of Neurosciences, vol. 19, no. 1, pp. 14–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Parikh, M. Koch, and R. K. Narayan, “Traumatic brain injury,” International Anesthesiology Clinics, vol. 45, no. 3, pp. 119–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Mbengue, S. Bhattacharjee, T. Pandharkar et al., “A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria,” Nature, vol. 520, no. 7549, pp. 683–687, 2015. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Cheng, W. E. Ho, F. Y. Goh et al., “Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway,” PLoS ONE, vol. 6, no. 6, Article ID e20932, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. O. Thanaketpaisarn, P. Waiwut, H. Sakurai, and I. Saiki, “Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways,” International Journal of Oncology, vol. 39, no. 1, pp. 279–285, 2011. View at Publisher · View at Google Scholar · View at Scopus